•
Chengda Pharmaceuticals Co. Ltd. (SHE: 301201), based in China, has announced the termination of its “Chengda Pharma Shanghai Institute of Pharmaceutical Research Project.” The company cited unfavorable macroeconomic conditions and its operational status as the primary reasons for this decision. The excess funds raised for the project will be retained…